Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Belcher

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Frontiers in Medicine|May 5, 2023
The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell diseaseJohn D Belcher, Selvaraj Nataraja, Fuad Abdulla, et al.
Haematologica|June 1, 2019
A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell diseaseJames G McArthur, Niels Svenstrup, Chunsheng Chen, et al.
Blood|January 8, 2010
The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic miceRobert P Hebbel, Gregory M Vercellotti, Betty S Pace, et al.
British Journal of Haematology|January 6, 2023
Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factorRan An, Yuncheng Man, Kevin Cheng, et al.
British Journal of Haematology|March 16, 2021
Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemiasFrancesca Vinchi, Richard Sparla, Sara T Passos, et al.
Blood|September 29, 2023
Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activationZalaya K Ivy, John D Belcher, Iryna A Khasabova, et al.
Blood Cells, Molecules & Diseases|July 24, 2018
Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patientsRayra Pereira Santiago, Caroline Conceição Guarda, Camylla Vilas Boas Figueiredo, et al.
Blood|January 27, 2023
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell diseaseErica M Sparkenbaugh, Michael W Henderson, Megan Miller-Awe, et al.
Journal of Clinical Medicine|February 15, 2022
Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical EvidenceThomas Gentinetta, John D Belcher, Valérie Brügger-Verdon, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Frontiers in Medicine|May 5, 2023
The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell diseaseJohn D Belcher, Selvaraj Nataraja, Fuad Abdulla, et al.
Haematologica|June 1, 2019
A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell diseaseJames G McArthur, Niels Svenstrup, Chunsheng Chen, et al.
Blood|January 8, 2010
The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic miceRobert P Hebbel, Gregory M Vercellotti, Betty S Pace, et al.
British Journal of Haematology|January 6, 2023
Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factorRan An, Yuncheng Man, Kevin Cheng, et al.
British Journal of Haematology|March 16, 2021
Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemiasFrancesca Vinchi, Richard Sparla, Sara T Passos, et al.
Blood|September 29, 2023
Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activationZalaya K Ivy, John D Belcher, Iryna A Khasabova, et al.
Blood Cells, Molecules & Diseases|July 24, 2018
Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patientsRayra Pereira Santiago, Caroline Conceição Guarda, Camylla Vilas Boas Figueiredo, et al.
Blood|January 27, 2023
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell diseaseErica M Sparkenbaugh, Michael W Henderson, Megan Miller-Awe, et al.
Journal of Clinical Medicine|February 15, 2022
Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical EvidenceThomas Gentinetta, John D Belcher, Valérie Brügger-Verdon, et al.
Pageof 13